REVOLUTION Medicines Closes $100 Million Financing to Advance Pipeline of Novel Therapies Addressing Frontier Targets in RAS-Dependent Cancers

from Venture Capital Access Online: Latest Venture Capital and Private Equity News https://ift.tt/2G6mk6S
via IFTTT